Erectile dysfunction frequently coexists with coronary artery disease and has been proposed as a potential marker for silent coronary artery disease in type 2 diabetes. In the present study, we comparatively assessed the structural and functional changes of both penile arteries (PAs) and coronary arteries (CAs) from a prediabetic animal model. PAs and CAs from 17-to 18-wk-old obese Zucker rats (OZRs) and from their control counterparts [lean Zucker rats (LZRs)] were mounted in microvascular myographs to evaluate vascular function, and stained arteries were subjected to morphometric analysis. Endothelial nitric oxide (NO) synthase (eNOS) protein expression was also assessed. The internal diameter was reduced and the wall-to-lumen ratio was increased in PAs from OZRs, but structure was preserved in CAs. ACh-elicited relaxations were severely impaired in PAs but not in CAs from OZRs, although eNOS expression was unaltered. Contractions to norepinephrine and 5-HT were significantly enhanced in both PAs and CAs, respectively, from OZRs. Blockade of NOS abolished endothelium-dependent relaxations in PAs and CAs and potentiated norepinephrine and 5-HT contractions in arteries from LZRs but not from OZRs. The vasodilator response to the phosphodiesterase 5 inhibitor sildenafil was reduced in both PAs and CAs from OZRs. Pretreatment with SOD reduced the enhanced vasoconstriction in both PAs and CAs from OZRs but did not restore ACh-induced relaxations in PAs. In conclusion, the present results demonstrate vascular inward remodeling in PAs and a differential impairment of endothelial relaxant responses in PAs and CAs from insulin-resistant OZRs. Enhanced superoxide production and reduced basal NO activity seem to underlie the augmented vasoconstriction in both PAs and CAs. The severity of the structural and functional abnormalities in PAs might anticipate the vascular dysfunction of the more preserved coronary vascular bed. vascular remodeling; endothelial dysfunction; coronary artery; penile artery; erectile dysfunction ERECTILE DYSFUNCTION (ED) is currently considered an early clinical manifestation of a more generalized vascular disease due to its high prevalence in patients with cardiovascular risk factors including diabetes, hypertension, hyperlipidemia, and tobacco abuse (32,46). ED is a common complication and an important cause of decreased quality of life in men with diabetes, and its prevalence is three times higher in type 1 and type 2 diabetic patients than in the general population (18,48).Growing epidemiological evidence associates the subsequent risk of ED with the presence of risk factors for coronary artery disease (CAD) such as obesity, hypertension, and dyslipidemia (32, 34). On the other hand, the rate of ED in patients with CAD is as high as 42-57%, and the incidence of ED in diabetic patients with silent ischemia is 34.8% versus 4.7% in those without silent ischemia (16,32,34). This has recently led to the suggestion that ED could be a potential marker for silent CAD in type 2 diabetes mellitus patie...